Konstantin Konstantinov - Insider Trading & Ownership

Entity
Individual
Location
C/O Codiak Biosciences, Inc., 500 Technology Square, 9 Th Floor, Cambridge, MA
Summary
The estimated net worth of Konstantin Konstantinov is at least $314K dollars as of May 20, 2024. Konstantin Konstantinov is the Director of REPLIGEN CORP and owns shares of REPLIGEN CORP (RGEN) stock worth about $314K.
All Insider Reports
All Insider Reports

Ownership of Konstantin Konstantinov

Insider Transactions Reported by Konstantin Konstantinov:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.